Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment

Condition:   Non-small Cell Lung CancerInterventions:   Drug: Aprepitant and placebo;   Drug: desloratadine and placeboSponsor:   Sun Yat-sen UniversityActive, not recruiting - verified January 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials